Author Interviews, Biomarkers, Diabetes, Diabetes Care, Johns Hopkins / 26.03.2020
Biomarker hsTroponin Predictive of Mortality Risk in Older Diabetics
MedicalResearch.com Interview with:
[caption id="attachment_53641" align="alignleft" width="150"] Olive Tang[/caption]
Olive Tang, MD/PhD Student
Johns Hopkins School of Medicine
[caption id="attachment_53642" align="alignleft" width="150"]
Dr. Selvin[/caption]
Elizabeth Selvin, PhD, MPH
Professor of Epidemiology & Medicine
Director, Cardiovascular and Clinical Epidemiology
Department of Epidemiology
Welch Center for Prevention, Epidemiology and Clinical Research and the
Johns Hopkins Bloomberg School of Public Health
MedicalResearch.com: What is the background for this study?
Response: The best approach to diabetes management in older adults is unclear. A new blood test called high-sensitivity troponin can detect damage to the heart, even in people without any signs or symptoms of heart disease.
Olive Tang[/caption]
Olive Tang, MD/PhD Student
Johns Hopkins School of Medicine
[caption id="attachment_53642" align="alignleft" width="150"] Dr. Selvin[/caption]
Elizabeth Selvin, PhD, MPH
Professor of Epidemiology & Medicine
Director, Cardiovascular and Clinical Epidemiology
Department of Epidemiology
Welch Center for Prevention, Epidemiology and Clinical Research and the
Johns Hopkins Bloomberg School of Public Health
MedicalResearch.com: What is the background for this study?
Response: The best approach to diabetes management in older adults is unclear. A new blood test called high-sensitivity troponin can detect damage to the heart, even in people without any signs or symptoms of heart disease.